June 20, 2025

Also in the News…

The Ophthalmologist brings you the top news stories and studies of the week

The Ophthalmologist

June 13, 2025

FDA Approves Amneal's Prednisolone Acetate Ophthalmic Suspension

Prednisolone acetate ophthalmic suspension, USP 1% is a sterile, topical anti-inflammatory agent for ophthalmic use and is indicated for treating steroid-responsive ocular inflammation.

Ophthalmology Management

June 11, 2025

PPV Glaucoma Risk

Study observes risk of pars plana vitrectomy patients developing glaucoma within five years of procedure

The Ophthalmologist

June 10, 2025

Proposed Combination Therapy Targets EVP and IOP

Qlaris Bio’s QLS-111-FDC would combine two mechanisms to improve glaucoma pressure control.

Glaucoma Physician

March 01, 2023

Treatment of Severe Ocular Surface Disease in the Glaucoma Patient

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Glaucoma Physician

September 01, 2024

An Update on SLT Clinical Trials

The ongoing COAST trial hopes to answer the question of which selective laser trabeculoplasty treatment approach is most effective.

Glaucoma Physician

March 01, 2023

Omni Surgical System Data From Five Sites Published

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Glaucoma Physician

March 01, 2024

Study Published of RadiusXR VR Perimetry Platform

Results show a 0.94 correlation in mean deviation and statistical noninferiority to traditional methods for staging glaucoma.

Glaucoma Physician

March 01, 2024

6-year Data Demonstrate Effective, Sustained IOP Reduction With iTrack Canaloplasty

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Glaucoma Physician